32
total announcements
AMANTA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹716 Cr
P/E (TTM)
44.3
EPS (TTM)
₹4.16
52W Low
₹92.00
52W High
₹209.95
Dividend Yield
0.00%
Price / Book
2.9
Debt / Equity
111.0
Revenue (TTM)
₹291 Cr
Gross Margin
65.94%
Operating Margin
14.32%
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended September 30, 2026.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted a disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market transfer of equity shares.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted disclosures under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding an off-market transaction of equity shares.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 16, 2026. The company has informed the Exchange regarding voting results.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about change in Management, appointment of Mr. Nimesh Patel as director retire by rotation and appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditor.
Amanta Healthcare Limited
Amanta Healthcare Limited held its 31st Annual General Meeting on September 16, 2026, through video conferencing. The meeting was attended by all directors and the company secretary. The proceedings were in compliance with the circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about a copy of newspaper publication in respect of a special window for transfer and dematerialization of physical shares.
Amanta Healthcare Limited
Amanta Healthcare Limited has commissioned a new SteriPort facility at its Kheda campus, enhancing container integrity and patient safety. The facility is expected to improve operational and financial efficiency, leading to EBITDA margin expansion.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange regarding 'Intimation - Regulation 36(1)(b) of the SEBI Listing Regulations'. The company has sent a letter to shareholders providing a web-link for accessing the Annual Report for the Financial Year 2025-26. The 31st Annual General Meeting (AGM) of Amanta Healthcare Limited is scheduled to be held on September 16, 2026, through Video Conferencing (VC) facility / Other Audio Visual Means (OAVM).
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about the dispatch of Annual Report of the 31st Annual General Meeting (AGM) and E-Voting Information through a newspaper publication.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about Notice of Annual General Meeting to be held on 16th September, 2026
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about a copy of newspaper publication - advertisement addressed to shareholders for the Annual General Meeting.
Amanta Healthcare Limited
Amanta Healthcare Limited held a Q1 FY27 Earnings Conference Call, reporting revenue of INR69 crores, up 5% year-on-year, and maintaining a healthy EBITDA margin of approximately 22%. The company is expanding its manufacturing capabilities and product portfolio, with its SteriPort platform contributing 44% of revenue and expected to witness strong customer acceptance. The expansion of the SteriPort facility has been delayed due to operational issues, but the company remains confident in its growth prospects.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of the fund raised through its public issue. The report, issued by CRISIL Ratings Limited, indicates that the company has not deviated from the objects of the issue.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about the publication of its financial results for the quarter ended June 30, 2026, in newspapers and on its website.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about Newspaper Publication of Financial Results for Quarter ended June 30, 2026.
Amanta Healthcare Limited
Amanta Healthcare Limited has submitted the audio recording of its post-results conference call held on August 6, 2026, which can be accessed on the company's website.
Amanta Healthcare Limited
Amanta Healthcare Limited announces Q1FY27 results with stable margins and strategic capacity build-out continuing. Revenue grew 5.4% YoY, EBITDA margin moderated to 22% from 24%, and PAT declined 5.6% YoY due to higher finance costs.
Amanta Healthcare Limited
Amanta Healthcare Limited has informed the Exchange about Investor Presentation on Financial Results of the Company for the quarter ended June 30, 2026.